EMVC
NEUTRALEMV Capital Portfolio Company PDS Biotech Reports Q1 2025 Results
The life sciences company reports Q1 2025 financial results and provides an update on its clinical programs and corporate developments.
EMV Capital
42.00GBX
3.70%
Market Cap
11.66M
Volume
6
0% of avg
P/E Ratio
-0.07
EPS (TTM)
-6.07
Beta
0.49
Day Range
0.00p - 0.00p
52 Week Range
0.00p42.00p80.50p
42.00p
Upcoming Events
May 30 - June 3, 2025
2025 ASCO Annual Meeting
High Impact Event
EMVC
NEUTRALEMV Capital Announces Director Dealings
The asset management firm has announced changes to its major shareholdings.
EMVC
NEUTRALEMV Capital Portfolio Company PDS Biotech Reports Full Year 2024 Results
The life sciences company reports its full year 2024 financial results and provides an update on its clinical programs, including the initiation of a Phase 3 trial for its lead candidate.
EMVC
GOODEMV Capital's Portfolio Company PDS Biotech Advances HPV16-Positive Head and Neck Cancer Therapy to Phase 3 Trial
The deeptech and life sciences VC firm's portfolio company PDS Biotech is advancing its lead immunotherapy candidate into a pivotal Phase 3 trial for a form of head and neck cancer, having cleared the regulatory pathway with the FDA.
EMVC
GOODEMV Capital Backed ProAxsis Announces Progress and Fundraise
The deeptech and life sciences VC firm's portfolio company reports strong financial and operational progress, including 92% revenue growth, reduced losses, and plans for a fundraise to support commercial and clinical development.
EMVC
NEUTRALEMV Capital Announces Change in Significant Shareholding
The venture capital firm announces a change in significant shareholding, with a director reducing their stake slightly but retaining a major holding.
EMVC
NEUTRALEMV Capital Grants Share Options to Directors
Venture capital firm EMV Capital grants share options to directors, aligning management incentives with shareholders.
EMVC
NEUTRALEMV Capital Invests in Q-Bot Fundraising
EMV Capital, a venture capital firm, announces its portfolio company Q-Bot has completed a £1.3 million fundraising round.
EMVC
NEUTRALDirector Reduces Stake in EMV Capital
Venture capital firm EMV Capital sees a minor decrease in director's shareholding.
EMVC
GOODEMV Capital Portfolio Company Wanda Health Raises £1 Million
Venture capital firm EMV Capital announces successful £1 million fundraising by its portfolio company Wanda Health, a leading remote patient monitoring and virtual care platform.